Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(15):1147-1152; doi:10.1093/jnci/93.15.1147
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Gu, J.
Right arrow Articles by Cheng, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gu, J.
Right arrow Articles by Cheng, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 15, 1147-1152, August 1, 2001
© 2001 Oxford University Press


REPORT

Molecular Evidence for the Independent Origin of Extra-ovarian Papillary Serous Tumors of Low Malignant Potential

Jian Gu, Lawrence M. Roth, Cheryl Younger, Helen Michael, Fadi W. Abdul-Karim, Shaobo Zhang, Thomas M. Ulbright, John N. Eble, Liang Cheng

Affiliations of authors: J. Gu, L. M. Roth, C. Younger, H. Michael, S. Zhang, T. M. Ulbright, J. N. Eble, L. Cheng, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis; F. W. Abdul-Karim, Case Western Reserve University School of Medicine, Cleveland, OH.

Correspondence to: Liang Cheng, M.D., Department of Pathology and Laboratory Medicine, Indiana University Medical Center, University Hospital 3465, 550 N. University Blvd., Indianapolis, IN 46202 (e-mail: lcheng{at}iupui.edu).

Background: Molecular data suggest that peritoneal tumors in women with advanced-stage ovarian papillary serous adenocarcinoma are monoclonal in origin. Whether the same is true for ovarian tumors of low malignant potential is not known. We compared peritoneal and ovarian tumors from women with advanced-stage ovarian papillary serous tumors of low malignant potential to determine whether the peritoneal tumors arose from the same clone as the ovarian tumors. Methods: We studied the clonality of 73 peritoneal and ovarian tumors from 18 women with advanced-stage ovarian papillary serous tumors of low malignant potential. Formalin-fixed, paraffin-embedded tumors and representative normal tissues were sectioned and stained with hematoxylin–eosin, representative sections from separate tumors were manually microdissected, genomic DNA was extracted from the microdissected tumors, and the polymerase chain reaction was used to amplify a CAG polymorphic site in the human androgen receptor locus on the X chromosome to determine the inactivation pattern of the X chromosome and the clonality of the tumors. Results: The pattern of X-chromosome inactivation could be determined from the tumors of 13 of 18 patients. Of the 13 patients, seven (54%) had nonrandom inactivation of the X chromosome, and six of the seven had different inactivation patterns in the peritoneal and ovarian tumors. Three of these patients also had different patterns of nonrandom X-chromosome inactivation in tumors from each ovary. The remaining six patients had random patterns of X-chromosome inactivation in the peritoneal and ovarian tumors. Conclusions: Our data suggest that peritoneal and ovarian tumors of low malignant potential arise independently.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
X. Wang, M. Wang, G. T. MacLennan, F. W. Abdul-Karim, J. N. Eble, T. D. Jones, F. Olobatuyi, R. Eisenberg, O. W. Cummings, S. Zhang, et al.
Evidence for Common Clonal Origin of Multifocal Lung Cancers
J Natl Cancer Inst, April 15, 2009; 101(8): 560 - 570.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Cheng, G. T. MacLennan, S. Zhang, M. Wang, M. Zhou, P.-H. Tan, S. Foster, A. Lopez-Beltran, and R. Montironi
Evidence for Polyclonal Origin of Multifocal Clear Cell Renal Cell Carcinoma
Clin. Cancer Res., December 15, 2008; 14(24): 8087 - 8093.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. M. Katona, T. D. Jones, M. Wang, F. W. Abdul-Karim, O. W. Cummings, and L. Cheng
Molecular Evidence for Independent Origin of Multifocal Neuroendocrine Tumors of the Enteropancreatic Axis.
Cancer Res., May 1, 2006; 66(9): 4936 - 4942.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. P. McCarthy, M. Wang, T. D. Jones, R. W. Strate, and L. Cheng
Molecular Evidence for the Same Clonal Origin of Multifocal Papillary Thyroid Carcinomas
Clin. Cancer Res., April 15, 2006; 12(8): 2414 - 2418.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. D. Jones, J. N. Eble, M. Wang, G. T. MacLennan, B. Delahunt, M. Brunelli, G. Martignoni, A. Lopez-Beltran, S. M. Bonsib, T. M. Ulbright, et al.
Molecular Genetic Evidence for the Independent Origin of Multifocal Papillary Tumors in Patients with Papillary Renal Cell Carcinomas
Clin. Cancer Res., October 15, 2005; 11(20): 7226 - 7233.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I.-M. Shih and R. J. Kurman
Molecular Pathogenesis of Ovarian Borderline Tumors: New Insights and Old Challenges
Clin. Cancer Res., October 15, 2005; 11(20): 7273 - 7279.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. D. Jones, M. Wang, J. N. Eble, G. T. MacLennan, A. Lopez-Beltran, S. Zhang, A. Cocco, and L. Cheng
Molecular Evidence Supporting Field Effect in Urothelial Carcinogenesis
Clin. Cancer Res., September 15, 2005; 11(18): 6512 - 6519.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Cheng, T. D. Jones, R. P. McCarthy, J. N. Eble, M. Wang, G. T. MacLennan, A. Lopez-Beltran, X. J. Yang, M. O. Koch, S. Zhang, et al.
Molecular Genetic Evidence for a Common Clonal Origin of Urinary Bladder Small Cell Carcinoma and Coexisting Urothelial Carcinoma
Am. J. Pathol., May 1, 2005; 166(5): 1533 - 1539.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
S. X. Liang, S. K. Chambers, L. Cheng, S. Zhang, Y. Zhou, and W. Zheng
Endometrial Glandular Dysplasia: A Putative Precursor Lesion of Uterine Papillary Serous Carcinoma. Part II: Molecular Features
International Journal of Surgical Pathology, October 1, 2004; 12(4): 319 - 331.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
R. P. McCarthy, S. Zhang, D. G. Bostwick, J. Qian, J. N. Eble, M. Wang, H. Lin, and L. Cheng
Molecular Genetic Evidence for Different Clonal Origins of Epithelial and Stromal Components of Phyllodes Tumor of the Prostate
Am. J. Pathol., October 1, 2004; 165(4): 1395 - 1400.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. M. Kernek, T. M. Ulbright, S. Zhang, S. D. Billings, O. W. Cummings, J. D. Henley, H. Michael, M. Brunelli, G. Martignoni, R. S. Foster, et al.
Identical Allelic Losses in Mature Teratoma and Other Histologic Components of Malignant Mixed Germ Cell Tumors of the Testis
Am. J. Pathol., December 1, 2003; 163(6): 2477 - 2484.
[Abstract] [Full Text]


Home page
JCOHome page
P. Morice, A. Thoury, J.C. Sabourin, S. Camatte, D. Atallah, J.P. Armand, P. Madelenat, P. Duvillard, and D. Castaigne
Unusual Abdominal and Pelvic Tumors: CASE 2. SPONTANEOUS REGRESSION OF PERITONEAL IMPLANTS IN BORDERLINE OVARIAN TUMOR AFTER SALPINGO-OOPHORECTOMY
J. Clin. Oncol., September 15, 2003; 21(18): 3536 - 3538.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. L.G. Sieben, S. M. Kolkman-Uljee, A. M. Flanagan, S. le Cessie, A.-M. Cleton-Jansen, C. J. Cornelisse, and G. J. Fleuren
Molecular Genetic Evidence for Monoclonal Origin of Bilateral Ovarian Serous Borderline Tumors
Am. J. Pathol., April 1, 2003; 162(4): 1095 - 1101.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. J. Gardner and M. J. Birrer
Ovarian Tumors of Low Malignant Potential: Can Molecular Biology Solve This Enigma?
J Natl Cancer Inst, August 1, 2001; 93(15): 1122 - 1123.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.